Page last updated: 2024-09-04

glucagon and 2-methylthio-n6-threonylcarbamoyladenosine

glucagon has been researched along with 2-methylthio-n6-threonylcarbamoyladenosine in 1 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(2-methylthio-n6-threonylcarbamoyladenosine)
Trials
(2-methylthio-n6-threonylcarbamoyladenosine)
Recent Studies (post-2010) (2-methylthio-n6-threonylcarbamoyladenosine)
26,0391,4983,054704

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atta, M; Fontecave, M; Fujimura, A; Kaitsuka, T; Kimura, S; Matsui, H; Michiue, H; Suzuki, T; Tomizawa, K; Watanabe, S; Wei, FY; Yamagata, K1

Other Studies

1 other study(ies) available for glucagon and 2-methylthio-n6-threonylcarbamoyladenosine

ArticleYear
Deficit of tRNA(Lys) modification by Cdkal1 causes the development of type 2 diabetes in mice.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:9

    Topics: Adenosine; Animals; Cell Line; Cyclin-Dependent Kinase 5; Diabetes Mellitus, Type 2; Genes, Reporter; Glucagon; Glucose; HEK293 Cells; Humans; Mice; Mice, Knockout; Mice, Transgenic; Nerve Tissue Proteins; Nucleic Acid Conformation; Proinsulin; Protein Biosynthesis; Recombinant Fusion Proteins; RNA, Transfer, Amino Acyl; Threonine; tRNA Methyltransferases

2011